EMA Withdrawn: Docefrez (docetaxel) — Sun Pharmaceutical Industries Europe B.V.

View source ↗

Summary

Withdrawn EMA entry for Docefrez (docetaxel) by Sun Pharmaceutical Industries Europe B.V.; listed indications include stomach neoplasms, adenoma, breast neoplas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenoma
• Breast Neoplasms
• Carcinoma Non-small-cell Lung
• Prostatic Neoplasms
• Stomach Neoplasms

Drugs mentioned

• Docefrez (docetaxel)

Snippet

Status: Withdrawn. Therapeutic area: Stomach Neoplasms;Adenoma;Breast Neoplasms;Carcinoma, Non-Small-Cell Lung;Prostatic Neoplasms. MAH: Sun Pharmaceutical Industries Europe B.V.. Decision date: 25/05/2012